Asthma drug may boost daily steps in severe cases
NCT ID NCT05404763
First seen Apr 25, 2026 · Last updated May 13, 2026 · Updated 1 time
Summary
This study tracks 62 adults with severe eosinophilic asthma to see if 6 months of mepolizumab treatment improves their daily physical activity and exercise tolerance. The main measure is the number of steps taken each day. Researchers want to learn if the drug not only reduces asthma attacks but also helps patients move more easily.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lille University Hospital
Lille, France
Conditions
Explore the condition pages connected to this study.